781 related articles for article (PubMed ID: 31356182)
1. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma biomarkers of inflammation in acute ischemic stroke patients with underlying dementia.
Choi DW; Kim TS; Kim YS; Kim DJ
BMC Neurol; 2020 Aug; 20(1):293. PubMed ID: 32758167
[TBL] [Abstract][Full Text] [Related]
3. The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.
Michalak S; Kalinowska-Lyszczarz A; Rybacka-Mossakowska J; Zaborowski M; Kozubski W
J Neural Transm (Vienna); 2019 Feb; 126(2):149-158. PubMed ID: 30374596
[TBL] [Abstract][Full Text] [Related]
4. Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.
Ondruschka B; Woydt L; Bernhard M; Franke H; Kirsten H; Löffler S; Pohlers D; Hammer N; Dreßler J
Int J Legal Med; 2019 May; 133(3):871-881. PubMed ID: 30167776
[TBL] [Abstract][Full Text] [Related]
5. Delirium in patients with acute ischemic stroke admitted to the non-intensive stroke unit: Incidence and association between clinical features and inflammatory markers.
Kozak HH; Uğuz F; Kılınç İ; Uca AU; Serhat Tokgöz O; Akpınar Z; Özer N
Neurol Neurochir Pol; 2017; 51(1):38-44. PubMed ID: 27816188
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of selected biochemical markers of brain damage for functional outcome in ischaemic stroke patients.
Sienkiewicz-Jarosz H; Gałecka-Wolska M; Bidziński A; Turzyńska D; Sobolewska A; Lipska B; Płaźnik A; Ryglewicz D
Neurol Neurochir Pol; 2009; 43(2):126-33. PubMed ID: 19484689
[TBL] [Abstract][Full Text] [Related]
7. [A panel of serum biomarkers, including damage, apoptosis and neurotrophic markers, for the assessment of prognosis of the course of ischemic stroke].
Chukanova AS; Gulieva MS; Chukanova EI; Bagmanyan SJ
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8. Vyp. 2):48-53. PubMed ID: 36036143
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection.
Worthmann H; Tryc AB; Dirks M; Schuppner R; Brand K; Klawonn F; Lichtinghagen R; Weissenborn K
J Neuroinflammation; 2015 Jan; 12():13. PubMed ID: 25613713
[TBL] [Abstract][Full Text] [Related]
9. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
[TBL] [Abstract][Full Text] [Related]
10. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
[TBL] [Abstract][Full Text] [Related]
11. [Biomarkers of brain damage and inflammation in patients with acute cerebral ischemia].
Voznyuk IA; Pivovarova LP; Gogoleva EA; Osipova IV; Ariskina OB; Morozova EM; Chernyavsky IV; Markelova EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8. Vyp. 2):54-60. PubMed ID: 36036144
[TBL] [Abstract][Full Text] [Related]
12. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
Lindblad C; Nelson DW; Zeiler FA; Ercole A; Ghatan PH; von Horn H; Risling M; Svensson M; Agoston DV; Bellander BM; Thelin EP
J Neurotrauma; 2020 Jun; 37(12):1381-1391. PubMed ID: 32013731
[TBL] [Abstract][Full Text] [Related]
13. Low Concentration of BDNF in the Acute Phase of Ischemic Stroke as a Factor in Poor Prognosis in Terms of Functional Status of Patients.
Lasek-Bal A; Jędrzejowska-Szypułka H; Różycka J; Bal W; Holecki M; Duława J; Lewin-Kowalik J
Med Sci Monit; 2015 Dec; 21():3900-5. PubMed ID: 26656843
[TBL] [Abstract][Full Text] [Related]
14. Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array.
Huţanu A; Iancu M; Bălaşa R; Maier S; Dobreanu M
Acta Pharmacol Sin; 2018 Jul; 39(7):1228-1236. PubMed ID: 29926842
[TBL] [Abstract][Full Text] [Related]
15. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR;
Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091
[TBL] [Abstract][Full Text] [Related]
16. Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke.
An SA; Kim J; Kim OJ; Kim JK; Kim NK; Song J; Oh SH
Clin Biochem; 2013 Jun; 46(9):710-5. PubMed ID: 23462697
[TBL] [Abstract][Full Text] [Related]
17. Effect of diesel exhaust inhalation on blood markers of inflammation and neurotoxicity: a controlled, blinded crossover study.
Cliff R; Curran J; Hirota JA; Brauer M; Feldman H; Carlsten C
Inhal Toxicol; 2016; 28(3):145-53. PubMed ID: 26915823
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of immune capacity, infection and inflammation are associated with poor outcome and mortality after stroke - the PREDICT study.
Mengel A; Ulm L; Hotter B; Harms H; Piper SK; Grittner U; Montaner J; Meisel C; Meisel A; Hoffmann S
BMC Neurol; 2019 Jul; 19(1):148. PubMed ID: 31269910
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models.
Martínez-Sánchez P; Gutiérrez-Fernández M; Fuentes B; Masjuán J; Cases MA; Novillo-López ME; Díez-Tejedor E;
J Transl Med; 2014 Aug; 12():220. PubMed ID: 25086655
[TBL] [Abstract][Full Text] [Related]
20. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC
J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
